Savara Inc (NASDAQ:SVRA – Get Free Report) shot up 6.1% on Monday . The company traded as high as $4.22 and last traded at $4.20. 271,525 shares traded hands during trading, a decline of 69% from the average session volume of 883,007 shares. The stock had previously closed at $3.96. Analysts Set New Price Targets […]
New Gold (NYSE: NGD) recently received a number of ratings updates from brokerages and research firms: 6/3/2024 – New Gold was upgraded by analysts at Cibc World Mkts to a “strong-buy” rating. 6/3/2024 – New Gold was upgraded by analysts at CIBC from a “neutral” rating to an “outperformer” rating. They now have a $3.00 […]
PriceSmart (NASDAQ:PSMT – Get Free Report) was upgraded by investment analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Monday. Separately, Jefferies Financial Group upped their price target on shares of PriceSmart from $82.00 to $90.00 and gave the company a “buy” rating in a research […]
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) VP Elizabeth Crowley sold 38,597 shares of Celldex Therapeutics stock in a transaction dated Thursday, May 30th. The shares were sold at an average price of $33.64, for a total transaction of $1,298,403.08. Following the completion of the transaction, the vice president now directly owns 9,074 shares […]
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) Director Franz B. Humer sold 11,200 shares of the company’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $2.34, for a total value of $26,208.00. Following the completion of the sale, the director now owns 255,253 […]